Breaking News Instant updates and real-time market news.

F

Ford

$8.81

0.16 (1.85%)

12:04
10/15/18
10/15
12:04
10/15/18
12:04

Ford names Elena Ford Chief Customer Experience Officer

Ford announced that Elena Ford has been named Chief Customer Experience Officer. In this role, she will lead the organization responsible for creating a world-class customer experience throughout the entire ownership cycle. The company also announced that John Savona is named vice president, North American Manufacturing. In this role, Elena Ford will report to Joe Hinrichs, Ford president, Global Operations. Savona will be responsible for Ford's North America manufacturing footprint -- the company's largest with more than 30 manufacturing plants. Previously, Savona served as Ford's director of Global Manufacturing Quality.

  • 13

    Dec

F Ford
$8.81

0.16 (1.85%)

08/20/18
MSCO
08/20/18
NO CHANGE
Target $15
MSCO
Overweight
Ford risks high, but so is potential reward, says Morgan Stanley
Morgan Stanley analyst Adam Jonas believes Ford announcing plans to spend $11B on restructuring and then canceling its investor day may have may have the unintended consequence of raising expectations for a "big bang" of action. While acknowledging the wide range of potential outcomes, Jonas has an estimate for how Ford could recognize its planned $11B in restructuring charges over a 3-5 year period to achieve annual cost reductions of about $4B, giving it a payback period of just under 3 years that would "usually [be] a very good use of capital" by automotive standards, he tells investors. Jonas maintains an Overweight rating on Ford with a $15 price target, contending that the "risks are high, but so is the potential reward."
09/10/18
SBSH
09/10/18
NO CHANGE
Target $9.9
SBSH
Neutral
Ford price target lowered to $9.90 from $10.50 at Citi
Citi analyst Itay Michaeli lowered his price target for Ford (F) to $9.90 to reflect restructuring-related calls on cash. The analyst keeps a Neutral rating on the shares and continues to maintain his preference for General Motors (GM). Ford faces both fundamental and perception problems, whereas GM just faces the latter, Michaeli tells investors in a research note. While the company must deal with some legitimate China and trade headwinds, the degree of erosion that's implied by the pullback in the shares is overdone, the analyst contends.
09/19/18
VERF
09/19/18
NO CHANGE
VERF
Sell
E-tron may not be 'Tesla killer,' but still a 'real risk,' says Vertical Group
After attending Audi's (AUDVF) launch event for its e-tron SUV, Vertical Group analyst Gordon Johnson said he sees Audi's foray in the EV space as "a real risk" to Tesla (TSLA) and other EV auto makers including Chevy (GM) and Ford (F). The Electrify America charging network, owned by a JV of Audi parent Volkswagen (VLKAY) and funded by "Dieselgate," positions Audi's fast-charging ambitions among the most robust, if not the most robust, in the U.S. currently, added Johnson. He does not see Audi's forthcoming e-tron as a "TSLA Killer," but does not "see it a stretch to think of it as a potential TSLA Model X killer," he concludes in his note to investors. Johnson keeps a Sell rating on Tesla shares.
09/26/18
LEHM
09/26/18
NO CHANGE
Target $11
LEHM
Equal Weight
Ford price target lowered to $11 from $12 at Barclays
In a research note titled "'Going Further' isn't further enough," Barclays analyst Brian Johnson lowered his price target for Ford Motor to $11 and $12 and keeps an Equal Weight rating on the name. Likely restructuring plans are not enough to get us interested, Johnson tells investors after Ford cancelled its investor day. Ford's plan borrows ideas from other manufacturers around shifting product toward trucks, exiting unattractive geographies and rationalizing architectures, the analyst contends. He says that even if successful, he sees little earnings upside and limited potential for multiple expansion for Ford shares.

TODAY'S FREE FLY STORIES

PHM

PulteGroup

$39.44

1.2 (3.14%)

07:14
10/23/19
10/23
07:14
10/23/19
07:14
Recommendations
PulteGroup analyst commentary  »

PulteGroup price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 07

    Nov

MICT

MICT, Inc.

$0.41

-0.0558 (-12.08%)

07:14
10/23/19
10/23
07:14
10/23/19
07:14
Hot Stocks
MICT, Inc. receives $1.2M order for on-board computer »

MICT announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTRH

Waitr Holdings

$0.58

0.0105 (1.85%)

07:14
10/23/19
10/23
07:14
10/23/19
07:14
Downgrade
Waitr Holdings rating change  »

Waitr Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ALKS

Alkermes

$18.42

0.01 (0.05%)

07:14
10/23/19
10/23
07:14
10/23/19
07:14
Hot Stocks
Alkermes sees ALKS 3831 NDA for schizophrenia, bipolar I this quarter »

Alkermes CEO Richard Pops…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

SLGN

Silgan Holdings

$31.05

-0.02 (-0.06%)

07:14
10/23/19
10/23
07:14
10/23/19
07:14
Earnings
Silgan Holdings reports Q3 adj. EPS 76c, consensus 76c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

AKCA

Akcea Therapeutics

$18.09

-0.85 (-4.49%)

, IONS

Ionis Pharmaceuticals

$54.73

-0.53 (-0.96%)

07:13
10/23/19
10/23
07:13
10/23/19
07:13
Hot Stocks
Akcea Therapeutics promotes Kyle Jenne to CCO »

Akcea Therapeutics…

AKCA

Akcea Therapeutics

$18.09

-0.85 (-4.49%)

IONS

Ionis Pharmaceuticals

$54.73

-0.53 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 06

    Nov

  • 07

    Dec

CLF

Cleveland-Cliffs

$7.15

0.16 (2.29%)

07:12
10/23/19
10/23
07:12
10/23/19
07:12
Hot Stocks
Cleveland-Cliffs sees FY19 sales volume 19.5M long tons »

Sees FY19 production…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

EVGN

Evogene

$1.72

(0.00%)

07:11
10/23/19
10/23
07:11
10/23/19
07:11
Hot Stocks
Evogene subsidiary Biomica partners with Weizmann Institute »

Evogene subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

WGO

Winnebago

$42.79

0.47 (1.11%)

07:11
10/23/19
10/23
07:11
10/23/19
07:11
Hot Stocks
Winnebago CEO sees 'significant runway' for team, overall business »

CEO Michael Happe said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

SNV

Synovus

$34.07

-2.225 (-6.13%)

07:11
10/23/19
10/23
07:11
10/23/19
07:11
Downgrade
Synovus rating change  »

Synovus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CMG

Chipotle

$831.69

-20.195 (-2.37%)

07:10
10/23/19
10/23
07:10
10/23/19
07:10
Recommendations
Chipotle analyst commentary  »

Chipotle price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

BIIB

Biogen

$281.96

58.39 (26.12%)

07:09
10/23/19
10/23
07:09
10/23/19
07:09
Upgrade
Biogen rating change  »

Biogen upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WGO

Winnebago

$42.79

0.47 (1.11%)

07:09
10/23/19
10/23
07:09
10/23/19
07:09
Earnings
Winnebago reports Q4 EPS $1.01, consensus $1.00 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

HAL

Halliburton

07:09
10/23/19
10/23
07:09
10/23/19
07:09
Downgrade
Halliburton rating change  »

Halliburton downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ETON

Eton Pharmaceuticals

$6.43

0.765 (13.52%)

07:09
10/23/19
10/23
07:09
10/23/19
07:09
Recommendations
Eton Pharmaceuticals analyst commentary  »

Eton Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Mar

DPZ

Domino's Pizza

$258.95

1.56 (0.61%)

07:08
10/23/19
10/23
07:08
10/23/19
07:08
Initiation
Domino's Pizza initiated  »

Domino's Pizza…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 13

    Nov

  • 11

    Dec

CLF

Cleveland-Cliffs

$7.15

0.16 (2.29%)

07:08
10/23/19
10/23
07:08
10/23/19
07:08
Earnings
Cleveland-Cliffs reports Q3 EPS 33c, consensus 24c »

Reports Q3 revenue $556M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

TXN

Texas Instruments

$128.61

-2.32 (-1.77%)

07:08
10/23/19
10/23
07:08
10/23/19
07:08
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLAB

Silicon Labs

$106.80

-2.93 (-2.67%)

07:08
10/23/19
10/23
07:08
10/23/19
07:08
Hot Stocks
Breaking Hot Stocks news story on Silicon Labs »

Silicon Labs reports Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

ALKS

Alkermes

$18.42

0.01 (0.05%)

07:07
10/23/19
10/23
07:07
10/23/19
07:07
Earnings
Alkermes raises FY19 non-GAAP EPS view to 44c-57c from 36c-45c, consensus 34c »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

RCI

Rogers Communications

$50.73

0.09 (0.18%)

07:07
10/23/19
10/23
07:07
10/23/19
07:07
Earnings
Rogers Communications lowers FY19 revenue view to down 1% to up 1% »

Compares to previous…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SLAB

Silicon Labs

$106.80

-2.93 (-2.67%)

07:07
10/23/19
10/23
07:07
10/23/19
07:07
Earnings
Silicon Labs sees Q4 adjusted EPS 84c-94c, consensus 85c »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

BIIB

Biogen

$281.96

58.39 (26.12%)

07:06
10/23/19
10/23
07:06
10/23/19
07:06
Recommendations
Biogen analyst commentary  »

Biogen price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WM

Waste Management

$116.90

-0.36 (-0.31%)

07:06
10/23/19
10/23
07:06
10/23/19
07:06
Earnings
Waste Management expects to achieve FY19 adjusted EPS view $4.28-$4.38 »

Fish concluded, "We…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SLAB

Silicon Labs

$106.80

-2.93 (-2.67%)

07:06
10/23/19
10/23
07:06
10/23/19
07:06
Earnings
Silicon Labs reports Q3 adjusted EPS 96c, consensus 84c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.